Roles and therapeutic potential of metallothioneins in neurodegenerative diseases

Current Pharmaceutical Biotechnology

Volumn 14, Issue 4, 2013, Pages 408-413

  Hozumi, Isao ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; Amyotrophic lateral sclerosis; Fahr's disease; Metallothionein; Parkinson's disease

Indexed keywords

COPPER ION; MAGNESIUM ION; METALLOTHIONEIN; METALLOTHIONEIN I; METALLOTHIONEIN II; METALLOTHIONEIN III; ZINC ION;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ASTROCYTE; DEGENERATIVE DISEASE; DISEASE COURSE; FAHR DISEASE; HUMAN; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN EXPRESSION;

ANIMALS; ANTIOXIDANTS; BRAIN; HUMANS; METALLOTHIONEIN; NEURODEGENERATIVE DISEASES;

EQUIDAE;

EID: 84878770600     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/1389201011314040004     Document Type: Article

References (61)

1. Hozumi, I.; Asanuma, M.; Yamada, M.; Uchida, Y. Metallothione- ins and neurodegenerative diseases. J. Health Sci., 2004, 50(4), 323-331.
2. Uchida, Y.; Takio, K.; Titani, K.; Ihara, Y.; Tomonaga, M. The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein. Neuron, 1991, 7(2), 337-347.
3. Quaife, C.J.; Findley, S.D.; Erickson, J.C.; Froelick, J.G.; Kelly, E.J.; Zambrowics, B.P.; Palmiter, R.D. Induction of a new metal-lothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia. Biochemistry, 1994, 33(23), 7250-7259.
4. Choudhuri, S.; Kramer, K. K.; Berman, N. E. J.; Dalton, T. P.; Andrews, G. K.; Klaassen, C. D. Constitutive expression of metal-lothioneingenes in mouse brain. Toxicol. Appl. Pharmacol., 1995, 131(1), 144-154.
5. Hozumi, I.; Suzuki, J.S.; Kanazawa, H.; Hara, A.; Saio, M.; Inuzuka, T.; Miyairi, S.; Naganuma, A.; Tohyama, C. Metallothionein-3 is expressed in the brain and various peripheral organs of the rat. Neurosci. Lett., 2008, 438(1), 54-58.
6. Uchida, Y.; Gomi F.; Masumizu, T.; Miura, Y. Growth inhibitory factor prevents neurite extension and the death of cortical neurons caused by high oxygen exposure through hydroxyl radical scavenging. J. Biol. Chem., 2002, 277(35), 32353-32359.
7. Hozumi, I.; Koumura, A.; Kimura, A.; Hasegawa, T.; Honda, A.; Hayashi, Y.; Hashimoto, K.; Yamada, M.; Sakurai, T.; Tanaka, Y., Satoh, M.; Inuzuka T. High levels of copper, zinc, iron, and magnesium, but not calcium in the cerebrospinal fluid of patients with Fahr's disease. Case Rept. Neurol., 2010, 2, 46-51.
8. Rosen, D.R.; Siddique, T.; Patterson, D.; Figlewicz, D. A.; Sapp, P.; Hentati, A.; Donaldson, D.; Goto, J.; O'Regan, J. P.; Deng, H. X.; Rahmani, Z.; Krizus, A.; McKenna-Yasek, D.; Cayabyab, A.; Gaston, S. M.; Berger, R.; Tanzi, R. E.; Halperin, J. J.; Herzfeldt, B.; Bergh, R. V D.; Hung, W. Y.; Bird, T.; Deng, G.; Mulder, D. W.; Smyth, C.; Laing, N. G.; Soriano, E.; Pericak-Vance, M. A.; Haines, J.; Rouleau, G. A.; Gusella, J. S.; Horvitz, H. R.; Brown R. H. Jr. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature, 1993, 362, 59-62.
9. Greenway, M.J.; Andersen, P. M.; Russ, C.; Ennis, S.; Cashman, S.; Donaghy, C.; Patterson, V.; Swingler, R.; Kieran, D.; Prehn, J.; Morrison, K. E.; Green, A.; Acharya, K. R.; Brown, R. H. Jr.; Hardi-man, O. ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis. Nat. Genet., 2006, 38(4), 411-413.
10. Sreedharan, J.; Blair, I. P.; Tripathi, V. B.; Hu, X.; Vance, C.; Ro-gelj, B.; Ackerley, S.; Durnall, J.C.; Williams, K. L.; Buratti, E.; Baralle, F.; de Belleroche, J.; Mitchell, J. D.; Leigh, P. N.; AI-Chalabi, A.; Miller, C. C.; Nicholson, G.; Shaw, C. E. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science, 2008, 319(5870), 1668-1672.
11. Kwiatkowski, T. J. Jr.; Bosco, D. A.; Leclerc, A. L.; Tamrazian, E.; Vanderburg, C. R.; Russ, C.; Davis, A.; Gilchrist, J.; Kasarskis, E. J.; Munsat, T.; Valdmanis, P.; Rouleau, G. A.; Hosler, B. A.; Cortelli, P.; de Jong, P. J.; Yoshinaga, Y.; Haines, J. L.; Pericak-Vance, M. A.; Yan, J.; Ticozzi, N.; Siddique, T.; McKenna-Yasek, D.; Sapp, P. C.; Horvitz, H. R., Landers, J. E.; Brown, R. H. Jr. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science, 2009, 323, 1205-1208.
12. Vance, C.; Rogelj, B.; Hortobagyi, T.; De Vos, K. J.; Nishimura, A. L.; Sreedharan, J.; Hu, X.; Smith, B.; Ruddy, D.; Wright, P.; Gane-salingam, J.; Williams, K. L.; Tripathi, V.; AI-Saraj, S., AI-Chalabi, A.; Leigh, P. N.; Blair, I. P.; Nicholson, G.; de Belleroche, J.; Gallo, J. M.; Miller, C. C.; Shaw, C. E. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science, 2009, 323(5918), 1208-1211.
13. Maruyama, H.; Morino, H.; Ito, H.; Izumi, Y.; Kato, H.; Watanabe Y.; Kinoshita, Y.; Kamada, M.; Nodera, H.; Suzuki, H.; Komure, O.; Matsuura, S.; Kobatake, K.; Morimoto, N.; Abe, K.; Suzuki, N.; Aoki, M.; Kawata, A.; Hirai, T.; Kato, T.; Ogasawara, K.; Hi-rano, A.; Takumi, T.; Kusaka, H.; Hagiwara, K.; Kaji, R.; Kawa-kami, H. Mutation of optineurin in amyotrophic lateral sclerosis. Nature, 2010, 465(7295), 223-226.
14. Cleveland, D. W.; Rothstein, J. D. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat. Rev. Neuro-sci., 2001, 2, 806-819.
15. Boillée, S.; Velde, C.V.; Cleveland, D. W. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron, 2006, 52(1), 39-59.
16. Ito, Y.; Yamada, M.; Tanaka, H.; Aida, K.; Tsuruma, K.; Shima-zawa, M.; Hozumi, I.; Inuzuka, T.; Takahashi, H.; Hara, H. Involvement of CHOP, an ER-stress apoptptic mediator, in both human sporadic ALS and ALS model mice. Neurobiol. Dis., 2009, 36(3) 470-476.
17. Nagano, S.; Satoh, M.; Sumi, H.; Fujimura, H.; Tohyama, C.; Ya-nagihara, T.; Sakoda, S. Reduction of metallothioneins promotes the disease expression of familial amyotrophic lateral sclerosis mice in a dose-dependent manner. Eur. J. Neurosci., 2001, 13(7), 1363-1370.
18. Puttaparthi, K.; Gitomer, W. L.; Krishnan, U.; Son, M.; Rajendran, B.; Elliott, J. L. Disease progression in a transgenic model of familial amyotrophic lateral sclerosis is dependent on both neuronal and non-neuronal zinc binding proteins. J. Neurosci., 2002, 22(20), 8790-8796.
19. Ishigaki, S.; Niwa, J.; Ando, Y.; Yoshihara T.; Sawada, K.; Doyu, M.; Yamamoto, M.; Kato, K.; Yotsumoto, Y.; Sobue, G. Differentially expressed genes in sporadic amyotrophic lateral sclerosis spinal cords-screening by molecular indexing and subsequent cDNA microarray analysis. FEBS Lett., 2002, 531(2), 354-358.
20. Hozumi, I.; Yamada, M.; Uchida, Y.; Ozawa, K.; Takahashi, H.; Inuzuka, T. The expression ofmetallothioneins is diminished in the spinal cords of patients with sporadic ALS. Amyotroph. Lateral. Scler., 2008, 9, 294-298.
21. McCrate, M. E.; Kaspar, B. K. Physical activity and neuroprotec-tion in amyotrophic lateral sclerosis. Neuromolecular Med., 2008, 10(2), 108-117.
22. Kirkinezos, I. G.; Hernandez, D.; Bradley, W. G.; Moraes, C. T. Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis. Ann. Neurol., 2003, 53(6), 804-807.
23. Hashimoto, K.; Hayashi, Y.; Inuzuka, T.; Hozumi, I. Exercise induces metallothioneins in mouse spinal cord. Neuroscience, 2009, 163(1), 244-251.
24. Sakamoto, T.; Kawazoe, Y.; Uchida, Y.; Hozumi, I.; Inuzuka, T.; Watabe, K. Growth inhibitory factor prevents degeneration of injured adult rat motoneurons. Neuroreport, 2003, 14(17), 2147-2151.
25. Hozumi, I.; Uchida, Y.; Watabe, K.; Sakamoto, T.; Inuzuka, T. Growth inhibitory factor (GIF) can protect from brain damage due to stab wounds in rat brain. Neurosci. Lett., 2006, 395(3), 220-223.
26. Hashimoto, K.; Hayashi, Y.; Watabe, K.; Inuzuka, T.; Hozumi, I. Metallothionein-III prevents neuronal death and prolongs life span in amyotrophic lateral sclerosis model mice. Neuroscience, 2011, 189, 293-298.
27. Kanias, D.; Kapaki, E. Trace elements, age, and sex in amyotrophic lateral sclerosis disease. Biol. Trace Element Res., 1997, 56(2), 187-201.
28. Tokuda, E.; Ono, S., Ishige, K.; Naganuma, A.; Ito, Y.; Suzuki, T. Metallothionein proteins expression, copper and zinc concentrations, and lipid peroxidation level in a rodent model for amyotro-phic lateral sclerosis. Toxicology, 2007, 229, 33-41.
29. Kim, J.; Kim, T. Y.; Hwang, J. J.; Lee, Y. Y.; Shin, J. H.; Gwag, B. J.; Koh, J. Y. Accumulation of labile zinc in neurons and astrocytes in the spinal cords of G93A SOD-1 transgenic mice. Neurobiol. Dis., 2009, 34, 221-229.
30. Tokuda, E.; Ono, S.; Ishige, K.; Naganuma, A.; Ito, Y.; Suzuki, T. Ammonium tetrathiomolybdate delays onset, prolongs survivals, and slows progression of disease in a mouse model for amyotrophic lateral sclerosis. Exper. Neurol., 2008, 34, 122-128.
31. Squitti, R.; Bressi, F.; Pasqualetti, P.; Bonomini, C.; Ghidoni, R.; Binetti, G.; Gassetta, F.; Moffa, F.; Ventriglia, M.; Vernieri, F.; Rossini, P. M. Longitudinal prognostic value of serum "free" copper in patients with Alzheimer disease. Neurology, 2009, 72(1), 50-55.
32. Religa, D.; Strozyk, D.; Cherny, R. A.; Volitakis, I.; Haroutunian, V.; Winblad, B.; Naslund, J.; Bush, A. I. Elevated cortical zinc in Alzheimer disease. Neurology, 2006, 67(1), 69-75.
33. Zarranz, J. J.; Alegre, J.; Gómez-Esteban, J. C; Lezcano, E.; Ros, R.; Ampuero, I.; Vidal, L.; Hoenicka, J.; Rodriguez, O.; Atarés, B.; Llorens, V.; Tortosa, E. G.; de Ser, T.; Muñoz, D. J. The new mutation, E46K, of a-synuclein causes parkinson and Lewy body dementia. Ann. Neurol., 2003, 55(2), 164-173.
34. Kitada, T.; Asakawa, S.; Hattori, N.; Matsumine, H.; Yamamura, Y.; Minoshima, S.; Yokochi, M.; Mizuno, Y.; Shimizu, N. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature, 1998, 392, 605-608.
35. Maraganore, D. M.; Lesnick, T. G.; Elbaz, A.; Chartier-Harlin, M. C; Gasser, T.; Krüger, R.; Hattori, N.; Mellick, G. D.; Quattrone, A.; Satoh J.; Toda, T.; Wang, J.; Ioannidis, J. P.; de Andrade, M.; Rocca, W. A.; UCHL1 Global Genetics Consortium. UCHL1 is a Parkinson's disease susceptibility gene. Ann. Neurol., 2004, 55(4), 512-521.
36. Canet-Avilés, R. M.; Wilson, M. A.; Miller, D. W.; Ahmad R.; McLendon, C; Bandyopadhyay, S.; Baptista, M. J.; Ringe, D.; Petsko, G. A.; Cookson, M. R. The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc. Natl. Acad. Sci. U S A., 2004, 101(24), 9103-9108.
37. Valent, E. M.; Sergio Salvi, S.; Ialongo, T; Marongiu, R; Elia, A. E.; Caputo, V.; Romito, L.; Albanese, A.; Dallapiccola, B.; Bentivoglio, A. R. PINK1 mutations are associated with sporadic early-onset parkinsonism. Ann. Neurol., 2004, 56(3),336-341.
38. Smith, W. W.; Pei, Z.; Jiang, H.; Moore, D. J.; Liang, Y.; West, A. B.; Dawson, V. L.; Dawson, T. M.; Ross, C. A. Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration. Proc. Natl. Acad. Sci. U S A, 2005, 102(51), 18676-18681.
39. DeLong, M. R.; Juncos, J. L. Parkinson's disease and other movement disorders. In Harrison's principals of internal medicine, 16th. edition; McGraw-Hill, Ed.; Kasper, D.L.; Braunwald, E.; Fauci, A.S.; Hauser, S. L.; Longo, D. L.; Jameson, J. L.: New York, 2005, pp. 2406-2418.
40. Asanuma, M.; Miyazaki, I.; Higashi, Y.; Tanaka, K.; Haque, M. E.; Fujita, N.; Ogawa, N. Aggravation of 6-hydroxydopamine-induced dopaminergic lesions in metallothionein-I and -II knock-out mouse brain. Neurosci.Lett., 2002, 327, 61-67.
41. Miyazaki, I.; Sogawab, A. C; Asanumaa, M.; Higashi, Y.; Tanaka K.; Nakanishi, T.; Ogawa, N. Expression of metallothionein-III mRNA and its regulation by levodopa in the basal ganglia of hemi-parkinsonian rats. Neurosci. Lett., 2000, 293, 65-68.
42. Gorell, J. M.; Johnson, C. C.; Rybicki, B. A.; Peterson, E. L.; Kortsha, G. X.; Brown, G. G.; Richardson, R. J. Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease. Neurotoxicol., 1999, 20(2-3), 239-247.
43. Oyanagi, K.; Kawakami, E.; Kikuchi-Horie, K.; Ohara, K.; Ogata, K.; Takahama, S.; Wada, M.; Kihira, T.; Yasui, M. Magnesium deficiency over generations in rats with special references to the pathogenesis of the parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam. Neuropathol., 2006, 26(2), 115-128.
44. Manyam, B. V. What is and what is not 'Fahr's disease'. Parkinson relat. disord., 2005, 11(2),73-80.
45. Shibayama, H.; Kobayashi, H.; Nakagawa, M.; Yamada, K.; Iwata, H.; Iwai, K.; Takeuchi, T.; Mu-Qune, X.; Ishihara, R.; Iwase, S.; Kitoh, J. Non-Alzheimer non-Pick dementia with Fahr's syndrome. Clinical Neuropathol., 1992, 11(5), 237-250.
46. Kosaka, K. Diffuse neurofibrillary tangles with calcification: a new presenile dementia. J. Neurol. Neurosurg. Psychiatr., 1994, 57(5), 594-596.
47. Margoshes, M.; Vallee, B. L. A cadmium protein from equine kidney cortex. J. Am. Chem. Soc, 1957, 79(19), 4813-4814.
48. Miyayama, T.; Suzuki, K. T.; Ogra, Y. Copper accumulation and compartmentalization in mouse fibroblast lacking metallothionein and copper chaperone. Atox1. Toxicol. Appl. Pharm., 2009, 237, 205-213.
49. Sato, M.; and Bremner, I. Oxygen free radicals and metallothionein. Free Rad. Biol. Med., 1993, 14 (3), 325-337.
50. Kim, C. H.; Kim, K. J.; Lee, J and Ahn, Y. S. Zinc-induced NF- K. J.; Lee, can be modulated by changes in the intracellular metallothionein level. Toxicol. Appl. Pharm., 2003, 190, 186-196.
51. Hozumi, I.; Inuzuka, T.; Ishiguro, H.; Hiraiwa, M.; Uchida, Y.; Tsuji, S. Immunoreactivity of growth inhibitory factor in normal rat brain and after stab wounds -an immunocytochemical study using confocal laser scan microscope. Brain Res., 1996, 741, 197-204.
52. Anezaki, T.; Ishiguro, H.; Hozumi, I.; Inuzuka, T.; Hiraiwa, M.; Kobayashi, H.; Yuguchi, T.; Wanaka, A.; Uda, Y.; Miyatake, T.; Tohyama, M. Expression of growth inhibitory factor (GIF) in normal and injured rat brains. Neurochem. Int., 1995, 27, 89-94.
53. Yamada, M.; Hayashi, S.; Hozumi, I.; Tsuji, S.; Takahashi, H. Subcellular localization of growth inhibitory factor in rat brain: light and electron microscopic immunohistochemical studies. Brain Res., 1996, 735(2), 257-264.
54. Moffatt, P.; Seguin, C. Expression of the gene encoding metal-lothionein-3 inorgans of the reproductive system. DNA Cell Biol., 1998, 17, 501-510.
55. Montoliu, C, Monfort, P.; Carrasco, J.; Palacios, O.; Capdevila, M.; Hidalgo, J.; Felipo, V. Metallothionein-III prevents glutamate and nitric oxide neutotoxicity in primary cultures of cerebellar neurons. J. Neurochem., 2000, 75, 266-273.
56. Uchida, Y.; Gomi, F.; Masumizu, T.; Miura Y. Growth inhibitory factor prevents neurite extension and the death of cortical neurons caused by high oxygen exposure through hydroxyl radical scavenging. J. Biol. Chem., 2002, 277, 32353-32359.
57. Hozumi, I.; Uchida, Y.; Watabe, K.; Sakamoto, T.; Inuzuka, T. Growth inhibitory factor (GIF) can protect from brain damage due to stab wounds in rat brain. Neurosci.Lett., 2006, 395: 220-223.
58. Hozumi, I.; Inuzuka, T. H.; Hiraiwa, M.; Uchida, Y.; Anezaki, T.; Ishiguro, H.; Kobayashi H.; Uda, Y., Miyatake, T.; Tsuji, S. Changes of growth inhibitory factor after stab wounds in rat brain. Brain Res., 1995, 688, 143-148.
59. Kawashima, T.; Doh-uraa, K.; Torisu, M.; Uchida, Y.; Furuta, A.; Iwaki, T. Differential expression of metallothioneins in human prion diseases. Dement. Geriatr. Cogn. Disord., 2000, 11(5), 251-262.
60. Koumura, A.; Hamanaka, J.; Shimazawa, M.; Honda, M.; Tsuru-maa, K.; Uchida, Y.; Hozumi, I.; Satoh, M.; Inuzuka, T.; Hara, H. Metallothionein-III knockout mice aggravates the neuronal damage after transient focal cerebral ischemia. Brain Res., 2009, 1292(25), 148-154.
61. Koumura, A., Kakefuda, K.; Honda, A.; Ito, Y.; Tsuruma, K.; Shimazawa, M.; Uchida, Y., Hozumi, I.; Satoh, M.; Inuzuka, T.; Hara, H. Metallothionein-3 deficient mice exhibit abnormalities of psychiatric behaviors. Neurosci. Lett., 2009, 467(1), 11-14.